Diclofenac dose study for alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether different doses of diclofenac, an anti-inflammatory drug, can help people reduce heavy drinking. It looks at how the drug affects drinking patterns and overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 21 and 65 years old.
- You have been diagnosed with alcohol use disorder (any level of severity).
- You drink more than 14 drinks per week (men) or 7 drinks per week (women) over the past month.
- You have had at least 5 heavy drinking days (5 or more drinks for men, 4 or more for women) in the past month.
- You are not currently in treatment for alcohol use disorder and have not been in treatment in the last 30 days.
- You do not have certain medical conditions like heart, liver, or kidney problems, or a history of bleeding ulcers or blood clots.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
This trial tests if baclofen can help people with both anxiety and alcohol use disorder. It is an open-label study, meaning everyone knows they are taking the medication. Researchers want to see if it supports people in staying alcohol-free.
This study tests a new sublingual (under-the-tongue) medication for people with alcohol use disorder who have also had a traumatic life event. It aims to see if the medication can help reduce drinking and related symptoms.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This trial tests an experimental medication called AFA-281 to see if it's safe and could help reduce heavy drinking in people with moderate to severe alcohol use disorder. You must drink a high number of drinks per week to qualify.
This trial tests if a blood pressure medication called nimodipine can help reduce alcohol drinking in people with moderate to severe alcohol use disorder. You'll take the medication or a placebo and participate in drinking sessions to see how it affects your alcohol intake.
Hear when a new Alcohol-Related Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.